Feedback / Questions
MNA-001 - Muna Therap
https://www.prnewswire.com/news-releases/muna-therapeutics-announces-first-subjects-dosed-in-phase-1-trial-of-novel-oral-trem2-agonist-for-early-alzheimers-disease-302609065.html
Nov 10, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next